IP Library Granted Patent US 11,419,668
Granted Patent B2
US 11,419,668 · App. 16/221,138 · Granted Aug 23, 2022

Method and device for uterine fibroid treatment

Inventor: Jessica Grossman (Covington, KY)
Assignee: Gynesonics, Inc.
A61B18/1477A61B8/085A61B8/12A61B2018/00559A61B2018/143A61B2090/378A61B2090/3782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,419,668
App. No.
16/221,138
Granted
Aug 23, 2022
Kind
B2
Abstract

Methods and devices for both imaging and treating uterine fibroid tumors in one real-time system are provided. One minimally invasive method comprises introducing a sheath into a uterus and determining a location of a fibroid using a visualization element within or on the sheath. Upon identification, a portion of the sheath is steered to position at least one treatment needle at the determined location. The needle is then anchored in uterine tissue and the fibroid treated with the needle.

Claims (29)

1. A device for fibroid treatment, said device comprising:

a single probe having a distal end, a proximal end, and an axis, wherein the distal end is adapted to be introduced into a bodily cavity;

a visualization element within or on a distal portion of the probe, the visualization element capable of determining a location of a fibroid while the probe is in the bodily cavity; and

a needle deployment array comprising a first needle deployable from the single probe and a plurality of second needles deployable from the first needle,

wherein the plurality of second needles are deployable to converge or diverge within tissue of a fibroid within the field of view of the visualization element, and

wherein the plurality of second needles are adapted to be withdrawn entirely back into the probe after use.

2. A device as in claim 1 , wherein the visualization element comprises an ultrasonic transducer.

3. A device as in claim 2 , wherein the ultrasonic transducer comprises a phased array transducer having 64 elements or a mechanically scanned transducer.

4. A device as in claim 1 , wherein the treatment needle has an arcuate geometry which resists displacement.

5. A device as in claim 1 , wherein the treatment needles each comprise an electrode, antenna, hollow tube, or cutting tube.

6. A device as in claim 1 , wherein the treatment needle is formed from nitinol.

7. A device as in claim 1 , wherein the treatment needle delivers ablative energy or at least one therapeutic agent to the fibroid.

8. A device as in claim 1 , wherein the single probe, visualization element, and needle deployment array are integrally formed.

9. A device as in claim 1 , wherein the single probe, visualization element, and needle deployment array comprise separate, modular components.

10. A device as in claim 1 , wherein one or more of the single probe, visualization element, or needle deployment array is steerable, rotatable, deflectable, flexible, pre-shaped, or pre-formed.

11. A device as in claim 1 , wherein the plurality of second needles of the needle deployment array consists of two treatment needles.

12. A device as in claim 1 , wherein the plurality of second needles of the needle deployment array is self-anchoring.

13. A device as in claim 1 , wherein at least one needle of the needle deployment array is configured to deliver at least one therapeutic agent.

14. A device as in claim 1 , wherein at least one needle of the needle deployment array has a non-linear, arcuate, helical, cork screw, or curved geometry when deployed.

15. A device as in claim 1 , wherein at least one needle of the needle deployment array is configured to measure tissue impedance.

16. A device as in claim 1 , wherein at least one needle of the needle deployment array is configured to deliver ablative energy.

17. A device as in claim 16 , wherein the ablative energy is electrical, radiofrequency (RF), laser, microwave, freezing or cryogenic, ultrasound, high frequency ultrasound (HIFU), or radiative.

18. A device as in claim 1 , wherein the device is configured to be minimally invasive.

19. A device as in claim 18 , wherein the device is configured to be introduced into the bodily cavity through an orifice.

20. A device as in claim 1 , wherein at least a portion of the probe is steerable.

21. A device as in claim 1 , wherein the visualization element is configured to provide a real-time image of the bodily cavity while the probe is in the bodily cavity.

22. A device as in claim 1 , wherein the first needle is hollow and has an open distal end, and wherein at least one needle of the plurality of second needles is configured to extend out from the open distal end of the first needle.

23. A device as in claim 1 , wherein one or more of (i) the first needle or (ii) the plurality of second needles are deployable from one or more locations on the single probe proximal of the visualization element.

24. A device as in claim 1 , wherein the first needle and the plurality of second needles are deployable from locations proximal of the visualization element to converge or diverge within the tissue of the fibroid within the field of view of the visualization element.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: GROSSMAN, JESSICA
To: GYNESONICS, INC.
Reel/Frame 047784/0360 →
Continuity (7)
Continuation 15970428 · May 3, 2018
Continuation 15720199 · Sep 29, 2017
Continuation 12973642 · Dec 20, 2010
Continuation 11347018 · Feb 2, 2006
Provisional Application 60710712 · Aug 22, 2005
Provisional Application 60649839 · Feb 2, 2005
Related Publication 20190192217A1 · Jun 27, 2019
Cited By (2)
US 12,239,382 US 12,414,813